COMMUNIQUÉS West-GlobeNewswire
-
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
08/04/2026 -
Universal Door Meditation Center Hosts Free Public Celebration of Awakened Zen Master Thich Dieu Thien's 25-Year Milestone April 11 in Sugar Land, Texas
08/04/2026 -
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026 -
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
08/04/2026 -
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F »)
08/04/2026 -
Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance
08/04/2026 -
Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients
08/04/2026 -
Sanofi - Assemblée Générale Mixte du 29 avril 2026 - Mise à disposition des documents préparatoires
08/04/2026 -
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
08/04/2026 -
New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects
08/04/2026 -
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
08/04/2026 -
Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents
08/04/2026 -
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
08/04/2026 -
Spectral AI Names David McGuire, CPA, as Chief Financial Officer
08/04/2026 -
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
08/04/2026 -
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
08/04/2026 -
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
08/04/2026 -
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
08/04/2026 -
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
08/04/2026
Pages